News

On June 15, 2024, MBA Pharma attended the 9th Conference of the Ho Chi Minh City Wound Care Association, a prestigious forum gathering leading experts in wound care. At the event, MBA Pharma introduced its Hyalo4 product line, featuring 200kDa hyaluronic acid, a significant advancement in wound treatment.

As more and more people are interested in maintaining their health and figure, the trend of weight loss treatment is strongly shifting towards products of natural origin, safety and high efficiency. Among the products leading this trend, Formoline and Formoline L112 extra of Certmedica company have proven to be the top choice for those who want to lose weight safely and sustainably.

In October 2024, the Vietnamese skin care market will welcome a breakthrough product from the Netherlands – Cinoscar, an advanced scar treatment product line manufactured by BAP Medical. With a unique formula containing polysiloxanes, Cinoscar is designed to provide superior results in the treatment of keloid and hypertrophic scars, helping users restore smooth skin and inherent confidence.

Hyalo4, with its main ingredient being 200kDa hyaluronic acid, is not only a pioneering solution in wound care but also widely indicated for acute and chronic wounds. This product is highly effective in shortening healing time, tissue regeneration, and reducing treatment costs for patients.